Sinco Pharmaceuticals Holdings Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,129.93 million compared to CNY 847.04 million a year ago. Net income was CNY 61.92 million compared to CNY 75.28 million a year ago.

Basic earnings per share from continuing operations was CNY 0.03049 compared to CNY 0.0445 a year ago. Diluted earnings per share from continuing operations was CNY 0.03048 compared to CNY 0.0445 a year ago.